These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27368120)

  • 1. A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation Development.
    Toprani VM; Joshi SB; Kueltzo LA; Schwartz RM; Middaugh CR; Volkin DB
    J Pharm Sci; 2016 Aug; 105(8):2319-27. PubMed ID: 27368120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of polyethylene glycol-induced precipitation as predictive tool for protein solubility during formulation development.
    Hofmann M; Winzer M; Weber C; Gieseler H
    J Pharm Pharmacol; 2018 May; 70(5):648-654. PubMed ID: 28106257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high-throughput solubility screening assay for use in antibody discovery.
    Chai Q; Shih J; Weldon C; Phan S; Jones BE
    MAbs; 2019; 11(4):747-756. PubMed ID: 30913963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.
    Meza NP; Hardy CA; Morin KH; Huang C; Raghava S; Song J; Zhang J; Wang Y
    Mol Pharm; 2023 Nov; 20(11):5842-5855. PubMed ID: 37867303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a PEG precipitation method for solubility screening: a tool for developing high protein concentration formulations.
    Li L; Kantor A; Warne N
    Protein Sci; 2013 Aug; 22(8):1118-23. PubMed ID: 23740802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisit PEG-Induced Precipitation Assay for Protein Solubility Assessment of Monoclonal Antibody Formulations.
    Scannell MJ; Hyatt MW; Budyak IL; Woldeyes MA; Wang Y
    Pharm Res; 2021 Nov; 38(11):1947-1960. PubMed ID: 34647231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening techniques for rapid PEG-based precipitation of IgG4 mAb from clarified cell culture supernatant.
    Knevelman C; Davies J; Allen L; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):697-705. PubMed ID: 20014099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High throughput solubility and redissolution screening for antibody purification via combined PEG and zinc chloride precipitation.
    Gu Q; Li Z; Coffman JL; Przybycien TM; Zydney AL
    Biotechnol Prog; 2020 Nov; 36(6):e3041. PubMed ID: 32583625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent modulation strategy for superior antibody monomer/aggregate separation in cation exchange chromatography.
    Kluters S; Frech C; von Hirschheydt T; Schaubmar A; Neumann S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Dec; 1006():37-46. PubMed ID: 26520020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of antibodies by precipitating impurities using Polyethylene Glycol to enable a two chromatography step process.
    Giese G; Myrold A; Gorrell J; Persson J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():14-21. PubMed ID: 24036248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential precipitation of acidic variants from monoclonal antibody pools.
    Rumanek T; Kołodziej M; Piątkowski W; Antos D
    Biotechnol Bioeng; 2023 Jan; 120(1):114-124. PubMed ID: 36226348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Protein Conformation, Apparent Solubility, and Protein-Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody.
    Kalonia C; Toprani V; Toth R; Wahome N; Gabel I; Middaugh CR; Volkin DB
    J Phys Chem B; 2016 Jul; 120(29):7062-75. PubMed ID: 27380437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-4-Amino Acid Deletion in the V5 Region of HIV-1 Env gp120 Confers Viral Resistance to the Broadly Neutralizing Human Monoclonal Antibody, VRC01.
    Tachibana S; Sasaki M; Tanaka T; Inoue M; Ophinni Y; Kotaki T; Kameoka M
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1248-1257. PubMed ID: 28903577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions.
    Pindrus M; Shire SJ; Kelley RF; Demeule B; Wong R; Xu Y; Yadav S
    Mol Pharm; 2015 Nov; 12(11):3896-907. PubMed ID: 26407030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of PEG-induced precipitation with protein-protein interactions and aggregation rates of high concentration mAb formulations at 5 °C.
    Wälchli R; Fanizzi F; Massant J; Arosio P
    Eur J Pharm Biopharm; 2020 Jun; 151():53-60. PubMed ID: 32197816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.